Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cancer Pain 9Neoplasms 6Pain 4Prostatic Neoplasms 1Osteoarthritis 1Opioid-Induced Constipation 1Lymphoma, Follicular 1Inflammation 1Head and Neck Neoplasms 1Endobronchial Metastases 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Back Pain 1Agnosia 1Acute Pain 1

Interventions

Fluticasone-Salmeterol Drug Combination 2Fluticasone 2Diclofenac 2ziconotide 1secukinumab 1ropinirole 1aliskiren 1acetaminophen, codeine drug combination 1Venlafaxine Hydrochloride 1Thiotepa 1Tacrolimus 1Sublocade 1Ribavirin 1Radiotherapy 1Quinine 1Oxycodone 1Naloxone 1Ketamine 1Furosemide 1Filgrastim 1Fentanyl 1Escitalopram 1Donepezil 1Cyclophosphamide 1Buprenorphine, Naloxone Drug Combination 1Bimatoprost 1Artesunate 1Antilymphocyte Serum 1Amoxicillin-Potassium Clavulanate Combination 1Amlodipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Follicular × Oxycodone × Clear all
NCT00784810 2011-11-02

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

Napp Pharmaceuticals Limited

Phase 4 Completed
247 enrolled 9 charts
Lymphoid

Back Pain, Lymphoma, Follicular, Osteoarthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡